Lupin gets US FDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.2%
It is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.